Literature DB >> 33363001

A Nomogram for Pretreatment Prediction of Response to Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma.

Baoliang Guo1, Fusheng Ouyang1, Lizhu Ouyang1, Xiyi Huang2, Haixiong Chen1, Tiandi Guo1, Shao-Min Yang1, Wei Meng1, Ziwei Liu1, Cuiru Zhou1, Qiu-Gen Hu1.   

Abstract

BACKGROUND: Induction chemotherapy (IC) significantly improves the rate of larynx preservation; however, some patients could not benefit from it. Hence, it is of clinical importance to predict the response to IC to determine the necessity of IC. We aimed to develop a clinical nomogram for predicting the treatment response to IC in locally advanced hypopharyngeal carcinoma.
METHODS: We retrospectively include a total of 127 patients with locally advanced hypopharyngeal carcinoma who underwent MRI scans prior to IC between January 2014 and December 2017. The clinical characteristics were collected, which included age, sex, tumor location, invading sites, histological grades, T-stage, N-stage, overall stage, size of the largest lymph node, neutrophil-to-lymphocyte ratio, hemoglobin concentration, and platelet count. Univariate and multivariate logistic regression was used to select the significant predictors of IC response. A nomogram was built based on the results of stepwise logistic regression analysis. The predictive performance and clinical usefulness of the nomogram were determined based on the area under the curve (AUC), calibration curve, and decision curve.
RESULTS: Age, T-stage, hemoglobin, and platelet were four independent predictors of IC treatment response, which were incorporated into the nomogram. The AUC of the nomogram was 0.860 (95% confidence interval [CI]: 0.780-0.940), which was validated using 3-fold cross-validation (AUC, 0.864; 95% CI: 0.755-0.973). The calibration curve demonstrated good consistency between the prediction by the nomogram and actual observation. Decision curve analysis shows that the nomogram was clinically useful.
CONCLUSION: The proposed nomogram resulted in an accurate prediction of the efficacy of IC for patients with locally advanced hypopharyngeal carcinoma.
Copyright © 2020 Guo, Ouyang, Ouyang, Huang, Chen, Guo, Yang, Meng, Liu, Zhou and Hu.

Entities:  

Keywords:  advanced hypopharyngeal carcinoma; induction chemotherapy; nomogram; prediction; response

Year:  2020        PMID: 33363001      PMCID: PMC7761343          DOI: 10.3389/fonc.2020.522181

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  30 in total

1.  Long-term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx Preservation.

Authors:  Guillaume Janoray; Yoann Pointreau; Pascal Garaud; Sophie Chapet; Marc Alfonsi; Christian Sire; Eric Jadaud; Gilles Calais
Journal:  J Natl Cancer Inst       Date:  2015-12-16       Impact factor: 13.506

2.  Hemoglobin level influences tumor response and survival after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma.

Authors:  Yoichi Hamai; Jun Hihara; Junya Taomoto; Ichiko Yamakita; Yuta Ibuki; Morihito Okada
Journal:  World J Surg       Date:  2014-08       Impact factor: 3.352

3.  Peripheral Inflammation Markers of Chemosensitivity to Induction Chemotherapy in Hypopharyngeal Cancer Patients.

Authors:  Wei Sun; Jin-Qiang Huang; Lin Chen; Wei-Ping Wen
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2019-05-21       Impact factor: 1.538

4.  Use of Diffusion-Weighted Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Combined With Computed Tomography in the Response Assessment for (Chemo)radiotherapy in Head and Neck Squamous Cell Carcinoma.

Authors:  D P Noij; R M Martens; T Koopman; O S Hoekstra; E F I Comans; B Zwezerijnen; R de Bree; P de Graaf; J A Castelijns
Journal:  Clin Oncol (R Coll Radiol)       Date:  2018-10-11       Impact factor: 4.126

Review 5.  Current management strategy of hypopharyngeal carcinoma.

Authors:  Jimmy Yu Wai Chan; William Ignace Wei
Journal:  Auris Nasus Larynx       Date:  2012-06-17       Impact factor: 1.863

Review 6.  The Current Indications for Non-Surgical Treatment of Hypopharyngeal Cancer.

Authors:  Remco de Bree
Journal:  Adv Otorhinolaryngol       Date:  2019-02-12

7.  Head and neck squamous cell carcinoma: diagnostic performance of diffusion-weighted MR imaging for the prediction of treatment response.

Authors:  Ann D King; Kwok-Keung Chow; Kwok-Hung Yu; Frankie Kwok Fai Mo; David K W Yeung; Jing Yuan; Kunwar S Bhatia; Alexander C Vlantis; Anil T Ahuja
Journal:  Radiology       Date:  2012-11-14       Impact factor: 11.105

Review 8.  Survival trends in hypopharyngeal cancer: a population-based review.

Authors:  J Robert Newman; Timothy M Connolly; Elisa A Illing; Meredith L Kilgore; Julie L Locher; William R Carroll
Journal:  Laryngoscope       Date:  2014-09-15       Impact factor: 3.325

9.  Pretreatment Intra-Voxel Incoherent Motion Diffusion-Weighted Imaging (IVIM-DWI) in Predicting Induction Chemotherapy Response in Locally Advanced Hypopharyngeal Carcinoma.

Authors:  Wei Guo; Dehong Luo; Meng Lin; Bing Wu; Lin Li; Yanfeng Zhao; Liang Yang; Chunwu Zhou
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

Review 10.  Functional MRI for the prediction of treatment response in head and neck squamous cell carcinoma: potential and limitations.

Authors:  Ann D King; Harriet C Thoeny
Journal:  Cancer Imaging       Date:  2016-08-19       Impact factor: 3.909

View more
  1 in total

1.  Computed tomography-based radiomics signature as a pretreatment predictor of progression-free survival in locally advanced hypopharyngeal carcinoma with a different response to induction chemotherapy.

Authors:  Xiaobin Liu; Chuanqi Sun; Miaomiao Long; Yining Yang; Peng Lin; Shuang Xia; Wen Shen
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-02-25       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.